Everyday AI Express, February 26 — DuRui Pharmaceutical (301075.SZ) announced that the tender offer period for Wang Qingtai and Cao Xiaobing has expired. The acquirers and their concerted parties collectively hold 43.12 million shares, accounting for 53.90% of the total share capital. The company’s shareholding structure still meets listing requirements. The company’s stock will resume trading from February 27, 2026.
Daily Economic News
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Duori Pharmaceuticals: Wang Qingtai and Cao Xiaobing's tender offer period has ended, and the stock resumes trading
Everyday AI Express, February 26 — DuRui Pharmaceutical (301075.SZ) announced that the tender offer period for Wang Qingtai and Cao Xiaobing has expired. The acquirers and their concerted parties collectively hold 43.12 million shares, accounting for 53.90% of the total share capital. The company’s shareholding structure still meets listing requirements. The company’s stock will resume trading from February 27, 2026.
Daily Economic News